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Strategies to Restore Hearing
By Sydney N. Sheltz-Kempf
Abstract: We discuss strategies within the field to restore hearing in the context of a flat epithelia
model. This could assist in avoiding the limitations of current treatment options along
with the obstacles associated with cellular restoration attempts. A review of the important
genes required for the development, differentiation, and long-term maintenance of the
organ of Corti (OC) demonstrates that any future direction to regenerate hair cells
necessitates a better understanding of the gene expression in addition to the cells present
during the phalangeal scarring process and the flat epithelia environment. This
understanding could be achieved through the development of a characterized flat
epithelia, followed by complete regeneration of various sensory cell types in the correct
location that respond appropriately to noise stimuli. Of course, this strategy would have
to be modified for the different types and cellular manifestations of hearing loss. The
characterization of the flat epithelia model and the context of the genes can be further
manipulated for precise regeneration of a functional OC based on the cellular
environment within the specific patient’s cochlea.
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Background
Neurosensory hearing loss is one of the most prevalent sensory disorders,
with over 5% of the world’s population living with disabling hearing loss [40,
45]. In the United States alone, one in eight people over the age of 12 experience
hearing loss in both ears [35], and by age 60, approximately one-third of the
population has difficulty hearing [40]. Additionally, hearing loss at birth, known
as congenital hearing loss, is one of the most common chronic disorders in
children [27]. The hearing loss in these pediatric patients is due to genetic factors.
However, other causes of hearing loss include noise-induced hearing loss,
ototoxic drugs, and other environmental insults. In many cases of hearing loss, the
mechanosensory cells of the inner ear responsible for transforming sound waves
into electrical impulses are lost. The remaining tissue is characterized by the ‘flat
epithelia’ leftover when these sensory cells have died [20, 21, 50, 56, 57]. This
review will discuss leading strategies in the field to restore hearing, including the
limitations of the current treatment options. We will also discuss previous
attempts at cellular restoration within the inner ear, and the generation of genetic
tools in a mouse model that could be vital to design novel treatment options for
patients.
Anatomy of the Ear

The inner ear is split into two regions: the vestibular region and the
cochlea. While the vestibular system provides a sense of balance, the cochlea is
responsible for the sense of hearing as a result of a highly organized arrangement
of specific cell types. These cell types can be split into three different categories:
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the mechanosensory cells responsible for hearing, the supporting cells that help
maintain these mechanosensory cells, and the spiral ganglion neurons (SGNs) that
transmit the electrical signal produced by the mechanosensory cells to the
hindbrain [11, 12, 13, 22, 56]. These mechanosensory cells are called hair cells.
While these cells are not like the hair found on top of one’s head, they do have
small tufts of stereocilia on their apical surface that resemble small hairs.
The hair cells and the supporting cells run the entire length of the cochlea
in a region called the organ of Corti (OC) (Figure 1). The cochlea is a long, coiled
tube with two ends: the apex and the base. During development, the OC is formed
as a result of two opposing gradients of gene expression within the cochlea. In
mice, around embryonic day 12 (E12), the cells that will eventually become the
hair cells and supporting cells, collectively called prosensory cells, exit the cell
cycle in the apex of the cochlea. These prosensory cells will continue to
progressively exit the cell cycle towards the base until around E14. At E13.5, hair
cells start to differentiate within the mid-base, which spreads to the apex and the
far basal region over the next 3-4 days [14, 19, 30, 60].
In addition to these developmental gradients, an important distinction
between the basal and apical sections of the cochlea is that the hair cells in these
regions respond to different frequencies of sound. The cochlear base responds
best to high-frequency waves, while the cochlear apex optimally responds to
low-frequency waves [19, 60]. The SGNs that synapse onto hair cells in the base,
mid-base, and apex help establish a tonotopic map in the hindbrain that directly
corresponds to this gradient of frequencies [21, 22, 38, 71]. In cases of age-related
hearing loss, most people first lose their sense of hearing in the region of higher
frequencies before the hearing loss eventually progresses to the lower frequencies
[28]. As such, the main function of hair cells is to respond to the physical
movement of the stereocilia on their surface in order to release neurotransmitters
to SGNs for sound transduction.
There are four rows of hair cells in the OC: one row of inner hair cells and
three rows of outer hair cells (Figure 2).
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The two types of hair cells are connected to two categories of SGNs, Type I SGNs
and Type II SGNs, in order to serve two specific functions. Inner hair cells are
connected to the Type I SGNs and are responsible for the transduction of sound
information that will be consciously perceived, while the Type II SGNs synapse
on the outer hair cells and are involved in a modulatory feedback loop [21, 22,
5

38]. Regardless of their function, both hair cell types are braced by five different
types of supporting cells: inner and outer pillar cells, inner and outer phalangeal
cells, and border cells. The inner and outer pillar cells delineate respectively the
inner and outer hair cells and form a cavity within the OC, called the tunnel of
Corti, filled with a sodium-rich and potassium-poor extracellular fluid known as
perilymph [19, 73]. Perilymph is different from the potassium-rich and
sodium-poor extracellular fluid that comes into direct contact with the stereocilia
of the hair cell, which is known as endolymph. The ion composition of
endolymph is so unique that it is not found elsewhere in the body, while the ion
composition of perilymph is very similar to other extracellular fluids [73]. The
strict segregation of these two fluids between the stereocilia and the body of both
hair cell types is important for establishing the sensitive ion gradient required for
both types of SGNs to fire electrical signals to the hindbrain. The bodies of inner
hair cells come into contact with the perilymph because they are supported within
the inner phalangeal cells. Likewise, the bodies of outer hair cells sit within the
outer phalangeal cells. However, the stereocilia on the apical surface of both hair
cell types come into contact with endolymph [19, 73].
The OC is sandwiched between two nonsensory regions called the greater
epithelial ridge (GER) and the lesser epithelial ridge (LER). The inner and outer
border cells delineate the sensory cells in the OC from the nonsensory GER and
LER, respectively. The GER contains inner sulcus cells, while the LER contains
the outer sulcus cells. As the name suggests, the single row of inner hair cells
(IHCs) lies closest to the GER, while the three rows of outer hair cells (OHCs) lay
closest to the LER. Together, the hair cells and supporting cells comprise the
sensory region and are grouped as sensory cells, while the cells within the GER
and LER are considered non-sensory (Figure 2).
The specific organization of the cells within the OC can be further
visualized by immunohistochemistry for cell-specific proteins (Figure 2). The
single row of IHCs and the three rows of OHCs can be seen via the Myosin VIIA
antibody, which only labels hair cells. The actin stain Phalloidin binds to the
stereocilia on the top of the hair cells. The merged image demonstrates how the
hair cells are organized by type and stereocilia arrangement. Furthermore, the
Sox2 antibody will bind to all supporting cells underneath the hair cells in order
to visualize the bottom supporting layer of the OC. Together, these
immunohistochemistry images establish a complete picture of the sensory cell
types in the OC.
Histological Effects During Hearing Loss
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Complete hearing loss is characterized by the presence of a flat epithelia
absent of all sensory cells (Figure 3). After the sensory hair cells die, the inner
and outer phalangeal cells expand to replace them. This process is called
phalangeal scarring [21, 56, 57]. After phalangeal scar formation, all the sensory
supporting cells are replaced by a flat environment caused when the GER and
LER come together to fill this gap. The name ‘flat epithelia’ is inspired by the
cellular morphology of the flat inner and outer sulcus cells from these regions
joining together. Previous studies have shown that the process of creating a flat
epithelium can range from a few days to several months [26, 57, 70]. This cellular
7

environment has not been well-characterized, but it could be pivotal in hearing
restoration studies since it is the phenotype seen in many hearing loss patients [14,
20, 21, 56, 57, 70]. Gene expression is strictly maintained in the GER and LER
and can be visualized via in situ hybridization for the genes Fgf10 and Bmp4,
respectively (Figure 3) [34, 52]. Previous studies have attempted to regenerate
hair cells by converting supporting cells or nearby non-sensory GER cells into
hair cells through the ectopic expression of genes known to be important for hair
cell formation [1, 5, 24, 36, 42]. However, as shown in Figure 3, there are no
differentiated supporting cell types within the flat epithelia, and because of this,
these approaches would not easily translate into an effective treatment option for
hearing loss.
Aside from gene therapy, an alternative approach to treat hearing loss is
the injection of cells into the inner ear with the expectation that they would
survive and proliferate into sensory cells after the addition of prosensory factors.
The field of regenerative medicine has a history of using stem cells in order to
regenerate tissues, but the cochlea poses a unique problem due to the extracellular
fluid that comes into contact with the OC. First, the endolymph creates a toxic
environment for any non-native cell types due to the high potassium
concentration. Second, there is no stem cell niche in the inner ear. As a result,
previous studies have shown that human embryonic stem cells did not survive
more than one day post-injection into the inner ear [32, 46]. Other studies
attempted to inject HeLa cells into the ear due to their more robust nature and
potential to survive in this hostile cellular environment. While these cells survived
up to a week post-injection, these studies were also unsuccessful [31, 32, 50].
Another study attempted to inject neural stem cells into the cochlea with the
intention to generate functional SGNs. A small number of cells were generated
that resembled satellite cells and Type I SGNs, but these were not maintained
long-term [51]. These studies reiterated the specificity of the toxic
micro-environment of the cochlea to non-native cells but also demonstrated that
the cochlea might provide signals for the differentiation of the various cell types.
Due to this unique problem, current approaches in the field to treat hearing loss
predominantly focus on gene therapy and the manipulation of cell types in the
cochlea.
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Gene Expression

A novel approach to treat hearing loss is the use of gene therapy in order to
generate functional hair cells. Studying the development of the cochlea in a
mouse model allows for the identification of genes necessary to generate hair cells
normally. This is especially important due to the lack of a stem cell niche to study
in the inner ear. Therefore, genes discovered in these studies can be manipulated
in order to generate new hair cells in hearing loss models. Previous studies have
identified several transcription factors that influence the development of different
cell types in the OC. Atoh1, a basic helix-loop-helix (bHLH) transcription factor,
9

is found to be necessary for the differentiation of both inner and outer hair cells
(Figure 4) [5, 6, 75]. Due to its essential role within hair cells, Atoh1 has been the
primary gene of interest for several studies attempting to regenerate hair cells [5,
6, 24, 36, 47, 48, 75]. Furthermore, Atoh1 lends itself to manipulation because it
has two different enhancers and auto-regulates its own expression by binding to
one of its own enhancers [47, 48]. Another important transcription factor called
Sox2 is expressed in all the supporting cell types discussed in Figure 2, including
the inner and outer border cells, phalangeal cells, and pillar cells. It has also been
shown that the SOX2 protein acts in a physical complex with EYA1 and SIX1 in
order to regulate ATOH1 expression in the hair cells by physically binding to the
second Atoh1 enhancer [1, 12, 55]. This suggests that Atoh1 and Sox2 may work
together in order to create the specific organization of hair cells and supporting
cells. However, it is not that simple. Other studies have demonstrated that
Delta-Notch signaling regulates expression of Hes/Hey genes that may also play a
role in determining the specific patterning between hair cells and supporting cells
[4, 8, 42, 53].
In addition, previous studies have shown that there are other transcription
factors required for long-term maintenance of sensory cell types. For example, the
zinc-finger transcription factor called Gata3 is particularly interesting due to the
variance in its expression throughout both embryonic and postnatal development
[9, 10, 23, 34]. Gata3 is highly expressed alongside Sox2 in the supporting cells,
but both types of hair cells have low residual levels of Gata3 expression at
postnatal day 0 (P0) [34, 75]. While Gata3 is originally expressed in both the
GER and LER in early embryonic development, it is important to note that Gata3
is not expressed in these regions at P0. Because Gata3 is expressed in multiple
cell types at the early stages of development, but is highly restricted later on, it
has been suggested that Gata3 may be modifying the expression of other
transcription factors for the long-term survival of sensory cell types [21].
As previously mentioned, without SGN presents, these cell types will not
be functional. NeuroD1, a bHLH transcription factor in the same family as Atoh1,
is specifically expressed in the SGNs that synapse onto these hair cells [21, 22,

38, 49]. It is vital to note that bHLH transcription factors often form complex
regulatory networks in sensory systems, which is especially true in the ear [66].
Since NeuroD1 represses Atoh1 expression within SGNs, there is a negative
feedback loop between these two transcription factors in the ear [49]. It has been
suggested that the expression of NeuroD1 and the subsequent downregulation of
Atoh1 is key in determining which prosensory cells will become SGNs instead of
hair cells, or vice versa [11, 13, 43]. Expression of Atoh1 is still required for
proneurosensory cells to develop [5]. Another bHLH transcription factor,
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Neurog1, has a strong regulatory role and also seems to play an overlapping role
with Atoh1 in the ear. Early in development, at E 9.5, the prosensory progenitor
cells that will eventually become SGNs express Neurog1, and previous studies
have reported that Neurog1 expression increases the progenitor population and
cell expansion [37, 67, 71]. Interestingly, in the absence of Atoh1 or Neurog1
expression, no hair cells or SGNs form [5, 37]. It has also been shown that the
replacement of one Atoh1 gene with the Neurog1 gene will partially rescue this
phenotype, implying that these two transcription factors play a similar role even if
they are not a complete substitute for each other. While Neurog1 has a regulatory
role in order to increase the proneurosensory progenitor cells, it also acts in a
network with NeuroD1 and Atoh1 in order to influence which cells ultimately
become SGNs or hair cells. In conclusion, hair cell formation requires a network
of several transcription factors throughout development combined with different
gene expression gradients that are eventually restricted to certain cell types.
Current Treatment Options
There are typically only two types of treatment available to patients who
suffer from hearing loss: cochlear implants and hearing aids. Cochlear implants
do not rely on the hair cells, but rather directly stimulate the SGNs that relay
sound information from the ear to the hindbrain. These SGNs make up part of
cranial nerve VIII [78]. In order to work, cochlear implants require at least some
functional SGNs [72]. Interestingly, it has been shown in previous studies that
SGNs require support from the hair for survival [3, 29, 69, 71]. As a result, SGNs
may be lost long-term in patients with cochlear implants, rendering this treatment
a temporary one. Another practical limitation of cochlear implants includes the
lack of perception of music. While patients with cochlear implants can
comprehend speech and detect simple rhythms under normal hearing conditions,
this technology does not appropriately account for the perception of pitch, timbre,
or melody recognition [41]. Most patients who utilize cochlear implants report
that they no longer find the sound of music as enjoyable or maintain their personal
genre preference [41].
In contrast to cochlear implants, hearing aids amplify the sound to assist
with partial hearing loss, but they still require at least a small population of
functional hair cells in addition to SGNs in order for sound to be relayed to the
brain and interpreted [18, 33, 40] While this treatment option does allow patients
to listen to music, the use of hearing aids carries a heavy social stigma along with
limitations in noisy environments. This prevents most people who need hearing
aids from actually using them. Previous studies have reported that almost 80% of
people aged 54-70 who need hearing aids intentionally choose not to use them
[40]. Further investigations have shown that these patients attribute external
societal pressures in the media, self-perceived judgment, and struggles with
ageism and vanity as reasons for declining this treatment option [74].  The
problem of hearing loss and lack of effective treatments is further compounded
by the increase in average lifespan and continued rapid growth in the aging
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population[14, 44]. Therefore, the regeneration of sensory hair cells would be
preferable to the currently available treatment options.
Flat Epithelial Models of Hearing Loss

Based on previous studies and other attempts to restore hearing, gene
manipulation within the flat epithelia seems to have the most potential for the
successful regeneration of hair cells. All types of hearing loss are characterized by
the loss of sensory cells, which results in a flat epithelium. However, in order to
perform experiments within a flat epithelia model, the model itself must be
characterized. There are two methods to create a flat epithelium: 1) the
Pou4f3-DTR genetic mouse line and 2) antibiotic exposure. Uniquely, mice are
immune to diphtheria because their cells do not have the receptor on the plasma
membrane for the diphtheria toxin (DTX). Pou4f3 is a gene that is expressed early
in hair cell development (Figure 5). In this genetic model, the cells that express
Pou4f3 will also express the human receptor for the diphtheria toxin. After
injection with DTX, only the hair cells will die because only these cells within the
inner ear express the receptor [16, 62]. Using this technique to target the hair cells
specifically is similar to the method in the paper that first reported phalangeal
scarring [26, 50, 56, 57, 62]. The supporting cells are unharmed but are destroyed
as the enlarged phalangeal scars are replaced by the inner and outer sulcus cells of
the GER and LER, respectively. Characterization of the gene expression and cell
12

types in the flat epithelia will be possible since this model is easily repeated with
a single DTX injection. However, another option to create the flat epithelia is to
inject with antibiotics that have been shown to have ototoxic properties. For
example, gentamicin and neomycin are commonly-prescribed antibiotics, but both
have been shown to kill hair cells and sensory cells in the cochlea after high doses
or prolonged use [17, 58, 64, 76, 77]. Additionally, commonly-prescribed
chemotherapeutic drugs like cisplatin have also demonstrated ototoxicity at high
levels and after long-term use [61, 65]. The advantage of the diphtheria injection
model is that it should affect all the hair cells of the OC, while the model created
through antibiotics can be patchy in the OC or have different effects that change
along the length of the cochlea.
Once the field has a more complete understanding of the flat epithelia,
gene manipulation in this environment will be the next step in order to regenerate
a functional OC. One gene that may be important in altering the flat epithelia of
hearing loss patients is Gata3 (Figure 5). As previously described, Gata3 is
widely expressed throughout the early development of the ear, but it becomes
restricted at P0 and later ages [9, 10]. It is known that differential levels of
transcription factors determine the level of their function, which raises another
interesting question: why does Gata3 have varying levels of expression
throughout the ear? The implication is that Gata3 either has several different roles
throughout development or that Gata3 plays a specific role that is restricted to
certain prosensory regions as the cells within the ear differentiate. One way to
tease these questions apart is to determine the effects of Gata3 within the flat
epithelia. It has been previously shown that there is a constant low level of Gata3
expression in cells that border the OC within the GER and LER, which would be
present in a flat epithelia disease model created from either the DTR approach or
the antibiotic method [57]. Furthermore, Gata3 has been shown to be necessary
for the proper function of ATOH1, both initially and long-term [10, 75].
Regarding the second method, it has been previously suggested that
overexpression of Gata3 may have a protective function against antibiotic
ototoxicity because of its role in long-term maintenance of ectopic and
regenerated hair cells. Regardless of the method, the field will benefit from the
complete characterization of the flat epithelia model, with and without phalangeal
scarring. Furthermore, a more complete understanding of the role of Gata3 in the
development and long-term maintenance of sensory cell types in the OC can
direct studies for other novel treatments.
Conclusion
This paper discussed strategies within the field to restore hearing in the
context of a flat epithelia model that could alleviate the limitations of current
treatment options and avoid the obstacles associated with cellular restoration
attempts. A review of important genes required for the development,
differentiation, and long-term maintenance of the OC demonstrates that any future
direction to regenerate hair cells necessitates a better understanding of the gene
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expression as a whole. Specifically, regeneration of hair cells requires a more
complete understanding of the genes and cells present during the phalangeal
scarring process and within the resulting flat epithelia environment. As previously
suggested, this understanding could be achieved through the development of a
characterized flat epithelia, followed by complete regeneration of various sensory
cell types in the correct location that respond appropriately to noise stimuli [21].
Future directions will likely focus on the manipulation of genes that influence hair
cell development, for example, Gata3, within this flat environment. This
knowledge will assist in the design of treatments for hearing loss that does not
require certain cell types, like cochlear implants or hearing aids. Furthermore,
these novel treatment options can target the flat epithelia remaining in all types of
hearing loss.
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